Literature DB >> 20718919

Sparing of the hippocampus and limbic circuit during whole brain radiation therapy: A dosimetric study using helical tomotherapy.

J C Marsh1, B T Gielda, A M Herskovic, J A Wendt, J V Turian.   

Abstract

INTRODUCTION: The study aims to assess the feasibility of dosimetrically sparing the limbic circuit during whole brain radiation therapy (WBRT) and prophylactic cranial irradiation (PCI). METHODS AND MATERIALS: We contoured the brain/brainstem on fused MRI and CT as the target volume (PTV) in 11 patients, excluding the hippocampus and the rest of the limbic circuit, which were considered organs at risk (OARs). PCI and WBRT helical tomotherapy plans were prepared for each patient with a 1.0-cm field width, pitch = 0.285, initial modulation factor = 2.5. We attempted to spare the hippocampus and the rest of the limbic circuit while treating the rest of the brain to 30 Gy in 15 fractions (PCI) or 35 Gy in 14 fractions (WBRT) with V(100) >or= 95%. The quality of the plans was assessed by calculating mean dose and equivalent uniform dose (EUD) for OARs and the % volume of the PTV receiving the prescribed dose, V(100).
RESULTS: In the PCI plans, mean doses/EUD were: hippocampus 12.5 Gy/14.23 Gy, rest of limbic circuit 17.0 Gy/19.02 Gy. In the WBRT plans, mean doses/EUD were: hippocampus 14.3 Gy/16.07 Gy, rest of limbic circuit 17.9 Gy/20.74 Gy. The mean V(100) for the rest of the brain (PTV) were 94.7% (PCI) and 95.1% (WBRT). Mean PCI and WBRT treatment times were essentially identical (mean 15.23 min, range 14.27-17.5).
CONCLUSIONS: It is dosimetrically feasible to spare the hippocampus and the rest of the limbic circuit using helical tomotherapy while treating the rest of the brain to full dose.

Entities:  

Mesh:

Year:  2010        PMID: 20718919     DOI: 10.1111/j.1754-9485.2010.02184.x

Source DB:  PubMed          Journal:  J Med Imaging Radiat Oncol        ISSN: 1754-9477            Impact factor:   1.735


  13 in total

1.  Radiation treatment parameters for re-irradiation of malignant glioma.

Authors:  M Niyazi; M Söhn; S B Schwarz; P Lang; C Belka; U Ganswindt
Journal:  Strahlenther Onkol       Date:  2012-02-22       Impact factor: 3.621

Review 2.  Treatment of brain metastases in lung cancer: strategies to avoid/reduce late complications of whole brain radiation therapy.

Authors:  Mark G Shaw; David L Ball
Journal:  Curr Treat Options Oncol       Date:  2013-12

3.  Cognitive Sparing during the Administration of Whole Brain Radiotherapy and Prophylactic Cranial Irradiation: Current Concepts and Approaches.

Authors:  James C Marsh; Benjamin T Gielda; Arnold M Herskovic; Ross A Abrams
Journal:  J Oncol       Date:  2010-06-27       Impact factor: 4.375

4.  Adaptive IMRT using a multiobjective evolutionary algorithm integrated with a diffusion-invasion model of glioblastoma.

Authors:  C H Holdsworth; D Corwin; R D Stewart; R Rockne; A D Trister; K R Swanson; M Phillips
Journal:  Phys Med Biol       Date:  2012-11-29       Impact factor: 3.609

5.  Whole brain radiotherapy for brain metastasis.

Authors:  Emory McTyre; Jacob Scott; Prakash Chinnaiyan
Journal:  Surg Neurol Int       Date:  2013-05-02

6.  Neural stem cell sparing by linac based intensity modulated stereotactic radiotherapy in intracranial tumors.

Authors:  Julia Oehler; Tim Brachwitz; Thomas G Wendt; Nico Banz; Mario Walther; Tilo Wiezorek
Journal:  Radiat Oncol       Date:  2013-07-24       Impact factor: 3.481

7.  Hippocampal-sparing whole-brain radiotherapy using Elekta equipment.

Authors:  Alexander Nevelsky; Nantakan Ieumwananonthachai; Orit Kaidar-Person; Raquel Bar-Deroma; Haitam Nasrallah; Rahamim Ben-Yosef; Abraham Kuten
Journal:  J Appl Clin Med Phys       Date:  2013-05-06       Impact factor: 2.102

8.  Development of a modelling to correlate site and diameter of brain metastases with hippocampal sparing using volumetric modulated Arc therapy.

Authors:  Silvia Chiesa; Mario Balducci; Luigi Azario; Simona Gaudino; Francesco Cellini; Gian Carlo Mattiucci; Cesare Colosimo; Vincenzo Valentini
Journal:  Biomed Res Int       Date:  2013-10-09       Impact factor: 3.411

Review 9.  Why and how to spare the hippocampus during brain radiotherapy: the developing role of hippocampal avoidance in cranial radiotherapy.

Authors:  Tomas Kazda; Radim Jancalek; Petr Pospisil; Ondrej Sevela; Tomas Prochazka; Miroslav Vrzal; Petr Burkon; Marek Slavik; Ludmila Hynkova; Pavel Slampa; Nadia N Laack
Journal:  Radiat Oncol       Date:  2014-06-16       Impact factor: 3.481

10.  Hippocampal EUD in primarily irradiated glioblastoma patients.

Authors:  Raphael Bodensohn; Matthias Söhn; Ute Ganswindt; Gabriele Schupp; Silke B Nachbichler; Oliver Schnell; Claus Belka; Maximilian Niyazi
Journal:  Radiat Oncol       Date:  2014-12-06       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.